Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients

Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients

ObjectivesLittle is known about how various treatments impact the progression of interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients. Here, we compared ILD progression in RA patients treated with Janus kinase inhibitors (JAKi) or biological disease-modifying anti-rheumatic drugs (b...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shota Kurushima, Tomohiro Koga, Masataka Umeda, Naoki Iwamoto, Ritsuko Miyashita, Takatomo Tokito, Daisuke Okuno, Hirokazu Yura, Hiroshi Ishimoto, Takashi Kido, Noriho Sakamoto, Yukitaka Ueki, Hiroshi Mukae, Atsushi Kawakami
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Subjects:	rheumatoid arthritis interstitial lung disease RA-ILD JAK inhibitors methotrexate epithelial-mesenchymal transition
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501146/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?
by: Beatrice Maranini, et al.
Published: (2025-01-01)

Clinical Characteristics and Outcomes of Interstitial Lung Disease Patients with Acute Respiratory Failure Admitted to the ICU
by: Sourabh Pahuja, et al.
Published: (2024-12-01)

A study on the relationship of dyspnoea score, high-resolution computed tomographic scan, and pulmonary function tests in the evaluation of connective tissue disease-related interstitial lung disorders
by: Somenath Kundu, et al.
Published: (2024-07-01)

Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
by: Xiaoping Li, et al.
Published: (2025-01-01)

Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry
by: Mohammed Abdullah Saleem, et al.
Published: (2024-12-01)

Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
by: Jie Zhao, et al.
Published: (2025-02-01)

Management of Ectopic Pregnancy: Comparison of Systemic Methotrexate Administration and Surgical Treatment; A Retrospective Study
by: Ali Cenk Özay, et al.
Published: (2013-08-01)

Haematemesis and Malaena – Rare Presentations of Methotrexate Toxicity - A Case Report
by: Swati Aundhakar, et al.
Published: (2014-08-01)

Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome
by: Antonella Notarnicola, et al.
Published: (2022-03-01)

Fibroblasts in rheumatoid arthritis: novel roles in joint inflammation and beyond
by: Elpida Neofotistou-Themeli, et al.
Published: (2025-01-01)

National trends in treatments for ectopic pregnancy in Japan from 2010 to 2020: a retrospective observational study
by: Risa Ishida, et al.
Published: (2024-12-01)

Connective Tissue Disease‑Associated Interstitial Lung Disease (CTD‑ILD)
by: Cindy Mai
Published: (2024-11-01)

Diagnostic yield and safety of transbronchial lung cryobiopsy for diffuse parenchymal lung diseases diagnosis: Comparison between 1.7-mm and 1.9-mm probes
by: C. Ravaglia, et al.
Published: (2025-12-01)

A Rare Case of Methotrexate Induced Pancreatitis in Ectopic Pregnancy
by: Jiwon Choi, et al.
Published: (2023-04-01)

Histopathological and Immunohistochemical Evaluation of Methotrexate-Induced Gonadal Damage in Rats: Role of SCF, mTOR, and SIRT-1
by: Kübra Tuğçe KALKAN, et al.
Published: (2024-12-01)

Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study
by: Nicolás Tentoni, et al.
Published: (2024-09-01)

Enhancing ovarian cancer treatment: Synergistic effects of methotrexate (Methotrexate)- and quercetin-loaded chitosan nanoparticles
by: Hamed Dadashi, et al.
Published: (2024-12-01)

Efficacy and tolerability of methotrexate at a dose of 15 mg/week and 10 mg/week in patients with pulmonary sarcoidosis
by: V.K. Gavrysyuk, et al.
Published: (2021-12-01)

Frequency and Causes of Methotrexate Intolerance and Discontinuation in Rheumatoid Arthritis Patients in Qena Governorate
by: Sondos Mohammed Sayed, et al.
Published: (2024-07-01)

Tacrolimus in refractory juvenile dermatomyositis: Case report and review of literature
by: Anand Prahalad Rao, et al.
Published: (2020-01-01)

Protective effect of Nigella Sativa Oil against Methotrexate induced Hepatotoxicity in Children with Acute Lymphoblastic Leukemia Adel A. Hagag, Ahmed M. Abd Elaal, Ayman elsheik , Enas Arafa Elzamarany * From Pediatrics and Clinical pathology* Departm
by: adel abd elhaleim hagag
Published: (2014-08-01)

A Systematic Review about Cervical Pregnancy and our Experience
by: Konstantinos Nikolettos, et al.
Published: (2024-05-01)

Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer
by: Ayuob Aghanejad, et al.
Published: (2025-01-01)

Retrospective analysis of cases with low dose methotrexate-induced neutropenia
by: Elif Dinçses Nas, et al.
Published: (2024-11-01)

Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases
by: Nicolò Peccatori, et al.
Published: (2025-06-01)

Cationic Micelle-like Nanoparticles as the Carrier of Methotrexate for Glioblastoma Treatment
by: Tuğba Nur Aslan
Published: (2024-12-01)

Methotrexate induced lung injury in a patient with primary CNS lymphoma: A case report
by: puneet chhabra, et al.
Published: (2012-04-01)

Methotrexate induced nephrotoxicity: possible underlying mechanisms and promising natural protective agents in experimental models
by: Asmaa M. Algendy, et al.
Published: (2023-12-01)

Chemotherapy and cognitive function: comprehensive review on methotrexate‐induced chemobrain
by: Nadine C. Sabry, et al.
Published: (2023-12-01)

Methotrexate induced lung injury in a patient with primary CNS lymphoma : A case report
by: puneet chhabra, et al.
Published: (2012-01-01)

Impact of Methotrexate and 7‐Hydroxymethotrexate Exposure on Renal Toxicity in Pediatric Non‐Hodgkin Lymphoma
by: Hao Bing, et al.
Published: (2025-01-01)

Effects of repeated intra-silicone oil injections of methotrexate on proliferative vitreoretinopathy grade C: a multicenter randomized controlled trial
by: Ramin Nourinia, et al.
Published: (2024-11-01)

STING signaling contributes to methotrexate-induced liver injury by regulating ferroptosis in mice
by: Hong-fei Wang, et al.
Published: (2024-11-01)

Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing
by: Zhongbo Hu, et al.
Published: (2024-11-01)

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey
by: Emil Vilstrup Moen, et al.
Published: (2025-02-01)

Early detection of interstitial lung disease in rheumatic diseases: A joint statement from the Portuguese Pulmonology Society, the Portuguese Rheumatology Society, and the Portuguese Radiology and Nuclear Medicine Society
by: A. Morais, et al.
Published: (2025-12-01)

Application of Microsponge Drug Platform to Enhance Methotrexate Administration in Rheumatoid Arthritis Therapy
by: Noemi Fiaschini, et al.
Published: (2024-12-01)

Progressive anterior segment involvement of an infant with corneoscleral juvenile xanthogranuloma refractory to topical steroids
by: Sanjana Suraneni, et al.
Published: (2024-12-01)

Cervical Ectopic Pregnancy: A case report and review of literature
by: Gabriel Dogbanya, et al.
Published: (2024-12-01)

Development of machine learning models for predicting non-remission in early RA highlights the robust predictive importance of the RAID score-evidence from the ARCTIC study
by: Gaoyang Li, et al.
Published: (2025-02-01)